JP Stock MarketDetailed Quotes

4883 Modalis Therapeutics

Watchlist
  • 76
  • -1-1.30%
20min DelayMarket Closed May 1 15:30 JST
5.60BMarket Cap-2.66P/E (Static)

About Modalis Therapeutics Company

Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.

Company Profile

Symbol4883
Company NameModalis Therapeutics
Founded2016-01-14
MarketTSE Growth
Employees37
Fiscal Year Ends12-31
Address16-5 Nihombashi-Kabuto-cho Chuo-ku
Zip Code103-0023
Phone03-6822-4584

Company Executives

  • Name
  • Position
  • Salary
  • Haruhiko Morita
  • Representative Director and President
  • --
  • Toshio Furuta
  • Independent Director
  • --
  • Teruhisa Tashima
  • Independent Director
  • --
  • Miyuki Shimane
  • Independent Director
  • --
  • Joseph McCracken
  • Independent Director
  • --
  • Hideki Takeda
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More